Faslodex in McCune-Albright Syndrome

Clinical trial NCT00278915 · COMPLETED

Trial details

NCT number: NCT00278915
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Puberty, Precocious McCune-Albright Syndrome

Start date: 2006-01-31
Primary completion: 2009-12-08
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.